Zevra Therapeutics Inc.
(ZVRA)
undefined
undefined%
At close: undefined
8.38
-1.06%
After-hours Dec 13, 2024, 07:54 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -46.05M | -41.54M | -8.55M | -12.76M | -24.52M | -56.47M | -43.39M | -16.52M | -54.66M | -24.45M | -5.23M | -70.42K |
| Depreciation & Amortization | 1.01M | 944.00K | 257.00K | 273.00K | 304.00K | 324.00K | 336.00K | 175.00K | 84.00K | 74.76K | 68.00K | 62.56K |
| Stock-Based Compensation | 5.95M | 4.29M | 2.44M | 2.49M | 4.41M | 6.50M | 4.56M | 6.60M | 2.37M | 213.76K | 134.00K | 467.99K |
| Other Working Capital | 3.63M | 3.03M | -295.00K | 374.00K | -5.12M | -650.00K | -849.00K | 3.32M | 87.00K | 523.00K | -4.00K | - |
| Other Non-Cash Items | 5.55M | 18.05M | 460.00K | 7.25M | 3.19M | 3.71M | 6.87M | -30.24M | 29.95M | 8.82M | -985.00K | -4.43M |
| Deferred Income Tax | - | - | 16.20M | 435.00K | -2.00M | -5.98M | 164.00K | 6.89M | 1.91M | -789.32K | 1.56M | - |
| Change in Working Capital | - | -466.00K | -357.00K | 374.00K | -5.12M | -2.29M | -1.65M | 3.32M | 87.00K | 1.46M | 122.00K | - |
| Operating Cash Flow | -33.53M | -18.72M | 10.44M | -1.94M | -23.74M | -54.20M | -33.10M | -29.77M | -20.27M | -14.67M | -4.33M | -4.43M |
| Capital Expenditures | -296.00K | -93.00K | -102.00K | -33.00K | -26.00K | -21.00K | -181.00K | -643.00K | -135.00K | -48.72K | -51.00K | -18.94K |
| Acquisitions | -30.40M | -14.09M | - | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | -45.81M | -22.54M | -15.42M | - | - | - | -27.38M | -89.85M | -19.00M | - | - | - |
| Sales Maturities Of Investments | 59.12M | 36.63M | - | - | 3.26M | 33.35M | 54.97M | 44.65M | - | - | - | - |
| Other Investing Acitivies | - | -36.63M | -15.42M | - | 3.26M | 33.35M | 27.59M | -1.10M | -19.00M | 5.00K | 17.00K | 5.07M |
| Investing Cash Flow | -17.39M | -36.72M | -15.52M | -33.00K | 3.23M | 33.33M | 27.41M | -46.95M | -19.14M | -43.72K | -34.00K | 5.05M |
| Debt Repayment | 25.59M | 12.78M | -38.10M | 2.86M | 5.24M | -193.00K | -157.00K | 62.17M | 3.97M | 24.93M | 3.79M | -79.36K |
| Common Stock Repurchased | -3.45M | -4.72M | -2.81M | - | - | - | - | - | - | - | - | -65.00K |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 6.32M | 291.00K | 104.73M | -118.00K | -300.00K | -116.00K | -46.00K | -1.01M | -2.39M | -1.93M | - | - |
| Financial Cash Flow | 28.46M | 8.35M | 113.11M | 2.74M | 4.94M | 28.02M | -203.00K | 61.16M | 61.47M | 23.00M | 3.79M | 381.13K |
| Net Cash Flow | -22.42M | -46.88M | 108.02M | 767.00K | -15.56M | 7.15M | -5.89M | -15.56M | 22.06M | 8.29M | -573.00K | 2.54M |
| Free Cash Flow | -33.83M | -18.81M | 10.34M | -1.97M | -23.76M | -54.22M | -33.28M | -30.41M | -20.40M | -14.72M | -4.38M | -4.45M |